GlassScriptPhysician profile
Daniel Carl Demarco
NPI 1558320903
$7,043.84
in general payments reported to CMS, 2019-2025
9 companies · $212 in 2025
The $212 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,579 · 2020: $108 · 2023: $145 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $6,091.14 | 2019 | |
| Gyrus Acmi, INC. | $420.00 | 2019 | |
| Boston Scientific Corporation | $140.03 | 2019-2023 | Resolution 360 Clip |
| Abbvie INC. | $132.78 | 2019-2020 | |
| Novo Nordisk INC | $114.85 | 2025 | |
| Novo Nordisk As | $97.01 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.83 | 2023 | Entyvio |
| Merck Sharp & Dohme LLC | $15.15 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.05 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Demarco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.